25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug - Wikidata - wikimedia - TriplyDB

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug

http://www.wikidata.org/entity/Q26822943

about

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.Novel psychoactive substances of interest for psychiatry.Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions Drug abuse, relapse, and prevention education in malaysia: perspective of university students through a mixed methods approach.Patterns of Substance Use Across the First Year of College and Associated Risk Factors.4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity.A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.Drunkorexia: an emerging trend in young adults.4,4'-Dimethylaminorex ("4,4'-DMAR"; "Serotoni") misuse: A Web-based study.1-cyclohexyl-x-methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice.Oral fluid drug analysis in the age of new psychoactive substances.Cannabis and development of dual diagnoses: A literature review.MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.Analysis of 25 C NBOMe in Seized Blotters by HPTLC and GC-MS.An insight into the deep web; why it matters for addiction psychiatry?Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis.Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally?Detection of 25C-NBOMe in Three Related Cases.LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening pow Blunt Craniofacial Trauma as a Manifestation of Excited Delirium Caused by New Psychoactive Substances.Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.

P2860

Q26752739-A384D034-9A7A-4CB6-A9FD-24CEBE513EF5 Q26784276-462125C8-E04B-4A9B-B27C-700AF5E0054F Q26865329-3FFC4859-6E8C-4EB0-8C68-A0E1343ED034 Q30251771-27BF157F-8819-4EB2-AD6E-6180BD37F6C3 Q34504233-E1B023EA-4FFB-4022-B78A-9C2A425B9325 Q34667835-C8E70969-7FB9-4F7B-81D6-07C5D2F25570 Q34674320-C757309A-FE43-48D9-B31F-41648C6C0FD0 Q35575147-09FE1E23-0CDC-4091-AEDF-289EE6F64751 Q36209103-4ADE3CD7-0870-4257-9430-67299217FE0B Q38382285-11A0E36B-B6BC-46D0-ABBE-B02D6948DDAB Q38588258-7877D2AF-08A5-483C-A967-7E15EE15D4B7 Q38608674-319F292A-D73F-4900-A5B1-A11796C4DB41 Q38705409-A0BE4147-DFC5-4232-9C8C-2EF279C25489 Q38705413-E5365E51-DFCC-4169-82C1-748B91155E57 Q38768825-44958B2F-6F2B-494D-A471-CBA7B567524F Q38950359-653E7373-1E71-48A0-890B-BAE70E464B36 Q38985251-9C4E9946-EE52-4954-A96A-C0F636BDB275 Q39569585-D29A0AEB-92CF-484B-8CEA-312F1E0C2299 Q42156143-47FA357C-3798-448A-80D1-2FA3A77963AF Q45881546-8BD820EA-3AF7-408A-AFB0-9E94C1E2A4AA Q48060529-A4F9801C-7849-4A77-B2DF-88BA918B6A3D Q48346962-3036CEA2-74A3-46B2-AAF8-DE78BD834978 Q48721685-022ABC69-4268-4A93-A8B2-2B81B0EF4276 Q52760538-0748A133-40D9-423D-8517-9C4C858399D5 Q53137811-1327E072-D967-4D72-ACC5-B436E097E3A1 Q55080181-2B18DCE9-F9EF-4484-8809-F2A551721C68

P2860

25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug

http://www.wikidata.org/entity/Q26822943

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@ast

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@en

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@nl

type

label

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@ast

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@en

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@nl

prefLabel

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@ast

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@en

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@nl

P1433

Q26822943-4273BC83-B69E-4364-8FE5-6231DBF76C65

P1476

Q26822943-9FEC4231-A93E-46CF-84C9-42FA826874C4

P2093

Q26822943-0E26BE01-E790-493B-9EEB-CEDF97FD2825

Q26822943-47A23E4F-535B-4AFF-9082-877F06611DDA

Q26822943-4C76D301-7A52-46C4-9E35-353DC4E9457F

Q26822943-8DBC6E60-D892-406B-8B50-5CD1A08495EC

Q26822943-943422BD-8EB5-43DD-B6DE-82389DF8CFF1

Q26822943-97E5F1C4-0BD5-4BCE-AE6E-245FA5BBF6FF

Q26822943-ADEA4045-C25F-45A6-AC45-36E7FA084754

Q26822943-BD48DBBB-A1C2-4843-BFCD-238EC570A8A6

Q26822943-BE9BE2F5-BBE2-4C72-A628-3B1C1D305879

Q26822943-FE71CE4F-9BF0-4D4E-920D-D4AB5146DF85

P275

Q26822943-1B706E50-0F1B-43C7-AE53-EABB3E82D480

P2860

Q26822943-011E2434-840A-403E-8F5B-C7916C25F438

Q26822943-2CDA247C-D842-4FE1-A692-CF577E862E89

Q26822943-3C155BA2-95A0-429F-9AC6-2C051EEA9725

Q26822943-463D9267-3D0D-49BD-8BCA-7D2F3BD109E8

Q26822943-54949F85-2158-4093-B013-7891396F2ACF

Q26822943-568EACA4-15F7-442F-8462-D04166BF1B7C

Q26822943-66CB3513-A01E-41A0-A1C6-5045405A6684

Q26822943-695F0A31-3B7E-4CCF-9C0E-DEC0F9E9D7F9

Q26822943-6E7B32D1-56A0-44D4-A251-366E2B8C26A3

Q26822943-881EFA24-DD8C-45E7-B591-647714103AC9

P304

Q26822943-CE8F9C77-C442-4CE8-A4BF-A33B83FEAC68

P31

Q26822943-26A09904-0DA3-43A4-89CB-7E72108B234C

Q26822943-B7679A0C-D563-46D6-AC87-04A25D12FFF9

P3181

Q26822943-253CBBC7-D392-43D5-8C65-7DC0C54001A5

P356

Q26822943-645E605B-8952-4E7C-828D-57F204721AFB

P407

Q26822943-BFDC9755-2D7A-45BC-8987-E17BD024F631

P478

Q26822943-792A7DCC-2A57-450C-B67B-7BBF57BB2465

P50

Q26822943-CF2CEE8C-34F1-4B08-9FD0-0D5AE5F929F5

P5008

Q26822943-A894B2E3-0A93-42AC-99B9-93F470D3D06A

P577

Q26822943-08E7B723-BE19-46CE-87FE-C55887D21D53

Q26822943-FE69676A-8F0A-480E-B954-0084BAC22B84

P5875

Q26822943-8CCD917F-2988-43D4-9517-6411E31599D3

P698

Q26822943-E1A31A26-738D-4014-B8CC-B0493950C6A2

P921

Q26822943-2DFD80D2-BEF9-48AD-AE91-0F2086333AA4

Q26822943-B6FE6F7D-9D22-4B19-8C72-CB55B70C87DB

Q26822943-a05d9a4f-4d5d-8290-00dc-a31c00fb7836

Q26822943-b8800bc0-4185-2e4c-828c-8d9271e55c85

P932

Q26822943-76690005-C816-4508-92ED-2B613B5CF1A5

P3181

P356

P1433

BioMed Research International

P1476

25C-NBOMe: preliminary data on ...... dangerous hallucinogenic drug

@en

P2093

Eduardo Cinosi

http://www.w3.org/2001/XMLSchema#string

Fabrizio Schifano

http://www.w3.org/2001/XMLSchema#string

Flaminia Bolzan Mariotti Posocco

http://www.w3.org/2001/XMLSchema#string

Francesco Saverio Bersani

http://www.w3.org/2001/XMLSchema#string

Gabriella Albano

http://www.w3.org/2001/XMLSchema#string

Giovanni Martinotti

http://www.w3.org/2001/XMLSchema#string

Giuseppe Bersani

http://www.w3.org/2001/XMLSchema#string

Giuseppe Valeriani

http://www.w3.org/2001/XMLSchema#string

Ornella Corazza

http://www.w3.org/2001/XMLSchema#string

Pierluigi Simonato

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet

Use of unstructured event-based reports for global infectious disease surveillance

Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists

Drops of madness? Recreational misuse of tropicamide collyrium; early warning alerts from Russia and Italy

Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project.

Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.

Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly.

Adverse reactions to psychedelic drugs. A review of the literature.

25C-NBOMe--new potent hallucinogenic substance identified on the drug market.

P304

734749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2361

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2014/734749

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Rita Santacroce

P5008

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264629748

http://www.w3.org/2001/XMLSchema#string

P698

25105138

http://www.w3.org/2001/XMLSchema#string

P921

psychotropic drug

substance-related disorder

P932

4106087

http://www.w3.org/2001/XMLSchema#string